Eligibility of patients with type 2 diabetes for sodium–glucose cotransporter 2 inhibitor cardiovascular outcomes trials: a global perspective from the DISCOVER study
Stéphane Pintat, Peter Fenici, Niklas Hammar, Linong Ji, Kamlesh Khunti, Jesús Medina, Fengming Tang, Eric Wittbrodt, Filip Surmont
BMJ Open Diabetes Research and Care Mar 2019, 7 (1) e000627; DOI: 10.1136/bmjdrc-2018-000627
